Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Blood Advances
Published October 21, 2026
Glofitamab with polatuzumab vedotin in relapsed/refractory central nervous system lymphomas.
October 23, 2026
Medspoke
Medspoke
Blood Advances
Published October 21, 2026
00:00
--:--
Prospective phase 2 trial of high- and intermediate-intensity myeloablative conditioning for cord...
October 23, 2026
Share
Prospective phase 2 trial of high- and intermediate-intensity myeloablative conditioning for cord blood transplantation.
https://www.medspoke.co/channel_journal?id=683&tap_id=16145
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Blood Advances
Published October 21, 2026
High Initial Dose and Accelerated vs. Slow Titration Ropeginterferon Alfa-2b for Polycythemia Ver...
October 23, 2026
Why are you reporting this TALK?
